www射-国产免费一级-欧美福利-亚洲成人福利-成人一区在线观看-亚州成人

  Home>News Center>Bizchina
       
 

Drug maker expects sales growth
By Zhu Baoxia (China Daily)
Updated: 2004-02-27 10:10

Novartis AG, the Switzerland-based pharmaceutical researcher and developer, expects an annual 20-30 per cent growth of sales in China in the next five years.

Sales for the world's fifth-largest drug maker are expected to grow by 42.6 per cent this year, an increase of 28.8 percentage points over last year.

In 2002, sales on the Chinese mainland reached 1.14 billion yuan (US$137 million), an increase of 13.8 per cent over the previous year, according to Paul Lau, president of Novartis China branch.

This optimism is based on a series of plans that Novartis AG has made for its business expansion strategy on the Chinese mainland for the next few years.

In order to fulfill these targets, explained Lau, Novartis AG plans to bring its affiliated company Sandoz to China to explore the huge OTC market, further enlarge the scale of its production base in Changping, located in suburban Beijing, and launch at least two new patented drugs in China Sandostatin LAR, a treatment for cancer and Visudyne for age-related vision dysfunction.

Sandoz, another leading chemical/life science giant, was established in 1886. It was merged with two other companies, Ciba and Geigy, to create Novartis AG in 1996.

The simultaneous merger of Ciba-Geigy and Sandoz was the largest corporate deal in the world.

Starting in 2002, Novartis AG put all of its OTC pharmaceutical business under the Sandoz name. Last year, Sandoz reported an increase of 47 per cent in sales globally.

Sandoz will set up an office in China to carry out OTC business. At this time, Sandoz has no direct business with the Chinese mainland, Lau said. He did not give more detail about where and when the office will open.

He confirmed that the Novartis AG executive board has approved the further expansion of the production base in Changping in northern Beijing.

The expansion is expected to be completed before 2007.

With a total investment of 120 million yuan (US$14 million), the production capacity of the new plant is expected to triple from the present level and the variety of products will also increase, according to James Liu, president of Beijing Novartis Pharmaceutical Co Ltd.



 
  Story Tools  
   
  Related Stories  
   
China to intensify regulation over medicines
Manufacturers, Exporters, Wholesalers - Global trade starts here.

 

Advertisement
         
主站蜘蛛池模板: 免费aa在线观看 男人的天堂 | 日韩中文字幕在线看 | 女人张开腿让男人捅爽 | 日本不卡一区在线 | 99久热在线精品视频播放6 | 一级毛片牲交大片 | 加勒比久久综合 | 日本一在线中文字幕天堂 | 草草视频免费在线观看 | 亚洲系列第一页 | 欧美午夜免费观看福利片 | 久久精品成人免费网站 | 日产日韩亚洲欧美综合搜索 | 黄色在线不卡 | 欧美特欧美特级一片 | 日本精品久久 | 一级特黄国产高清毛片97看片 | 久久国产精品久久国产精品 | 一级待一黄aaa大片在线还看 | 久久影院yy6080 | 国产欧美日韩在线不卡第一页 | 成人亚州 | 欧美在线成人午夜网站 | 欧美成人在线免费观看 | 一本本久综合久久爱 | 99久热在线精品视频观看 | 一级a毛片 | 欧美日韩中文国产一区二区三区 | 欧美精品18videos性欧美 | 经典日韩| 在线视频观看国产 | 美女黄视频免费观看 | 欧美日韩精品高清一区二区 | 国产一级毛片在线 | 男人的天堂亚洲 | 日韩欧美在线综合网高清 | 国产欧美日韩综合精品一区二区三区 | 国产精品无码久久久久 | 久揄揄鲁一二三四区高清在线 | 一级毛片aaa| 日本不卡免费高清一级视频 |